Laurent Mosnier, PhD

Select Publications

• von Drygalski, Annette; Bhat, V.; Gale, A. J.; Averell, P. M.; Cramer, T. J.; Elias, Darlene J.; Griffin, John H.; Mosnier, Laurent O. An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms. Blood Advances 2020, 4, 3716-3727.

  View

• Mosnier, Laurent O. How much clotting is enough?. Blood 2020, 136, 651-652.

  View

• Heeb, Mary J.; Heeb, Mary J.; Fernandez, Jose A.; Yamashita, Atsuki; Mcdowell, Olivia R.; Guo, Zihan; Mosnier, Laurent O.; Mosnier, Laurent O.; Deguchi, Hiroshi; Griffin, John H.; Griffin, John H.; Mosnier, Laurent O.; Heeb, Mary J.; Griffin, John H. Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin.. Haematologica 2020, 105, e424-e427.

  View

• Zhao, X. Y.; Wilmen, A.; Wang, D. L.; Wang, X. Q.; Bauzon, M.; Kim, J. Y.; Linden, L.; Li, L.; Egner, U.; Marquardt, T.; Moosmayer, D.; Tebbe, J.; Gluck, J. M.; Ellinger, P.; McLean, K.; Yuan, S. J.; Yegneswaran, S.; Jiang, X. Q.; Evans, V.; Gu, J. M.; Schneider, D.; Zhu, Y.; Xu, Y. F.; Mallari, C.; Hesslein, A.; Wang, Y.; Schmidt, N.; Gutberlet, K.; Ruehl-Fehlert, C.; Freyberger, A.; Hermiston, T.; Patel, C.; Sim, D.; Mosnier, Laurent O.; Laux, V. Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia. Nature Communications 2020, 11.

  View

• Yamashita, A.; Zhang, Y. Q.; Sanner, Michel F.; Griffin, John H.; Mosnier, Laurent O. C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities. Journal of Thrombosis and Haemostasis 2020, 18, 1027-1038.

  View

• Basu, S.; Liang, H. P.; Hernandez, I.; Zogg, M.; Fields, B.; May, J.; Ogoti, Y.; Wyseure, T.; Mosnier, Laurent O.; Burns, R. T.; Carlson, K.; Weiler, H. Role of thrombomodulin expression on hematopoietic stem cells. Journal of Thrombosis and Haemostasis 2020.

  View